let's be realistic..., page-16

There's tax credits attached to Fonda that Reddy's might want. Also, top holders wanted to split the company so MGMT couldn't go pumping Fonda revenues into the oncology platform. If ACL:Fonda gets sold, instead of the rights to Fonda under ACL, then ACL:Fonda can be split up and shareholders(top holders) rewarded accordingly.... No "special dividends" needed. IMO ACL: Oncology could also offer ACL:Fonda holders options to buy into Oncology at a discount, which could help the revenue from Fonda leak back into oncology....